CD4 count at presentation for HIV care in the United States and Canada: are those over 50 years more likely to have a delayed presentation? - Wikidata - awgldk - TriplyDB

CD4 count at presentation for HIV care in the United States and Canada: are those over 50 years more likely to have a delayed presentation?

CD4 count at presentation for HIV care in the United States and Canada: are those over 50 years more likely to have a delayed presentation?

http://www.wikidata.org/entity/Q34499000

about

Perspectives on menopause and women with HIV Management of HIV/AIDS in older patients-drug/drug interactions and adherence to antiretroviral therapy HIV infection and older Americans: the public health perspective Relationship between minority nonnucleoside reverse transcriptase inhibitor resistance mutations, adherence, and the risk of virologic failure HIV-associated neurocognitive disorders: the relationship of HIV infection with physical and social comorbidities It's a Process: Reactions to HIV Diagnosis and Engagement in HIV Care among High-Risk Heterosexuals.Sex, age, race and intervention type in clinical studies of HIV cure: a systematic review.Epidemiological characteristics and predictors of late presentation of HIV infection in Barcelona (Spain) during the period 2001-2009.Sexual risk behaviors and HIV risk among Americans aged 50 years or older: a review Clinical, demographic and laboratory parameters at HAART initiation associated with decreased post-HAART survival in a U.S. military prospective HIV cohort.Risk factors for mortality during antiretroviral therapy in older populations in resource-limited settings.Trends and Differences Among Three New Indicators of HIV Infection Progression.The Virological and Immunological Characteristics of the HIV-1-Infected Population in Brazil: From Initial Diagnosis to Impact of Antiretroviral Use.Human Immunodeficiency Virus Infection Newly Diagnosed at Autopsy in New York City, 2008-2012.Comparing longitudinal CD4 responses to cART among non-perinatally HIV-infected youth versus adults: Results from the HIVRN Cohort.A picture is worth a thousand words: maps of HIV indicators to inform research, programs, and policy from NA-ACCORD and CCASAnet clinical cohorts.Older HIV-infected patients on antiretroviral therapy have B-cell expansion and attenuated CD4 cell increases with immune activation reduction.Socioeconomic Status and Survival of People with Human Immunodeficiency Virus Infection before and after the Introduction of Highly Active Antiretroviral Therapy: A Systematic Literature Review.Accelerated aging of selective brain structures in human immunodeficiency virus infection: a controlled, longitudinal magnetic resonance imaging study.Late HIV presentation: epidemiology, clinical implications and management.HIV Care Initiation Delay among Rural Residents in the Southeastern United States, 1996 to 2012.Assessment of recent HIV testing among older adults in the United States.Factors associated with late diagnosis of HIV infection and missed opportunities for earlier testing.Profiles of Elderly People Infected with HIV and Response to Antiretroviral Treatment in Burkina Faso: A Retrospective Cohort Study.Correlates of recent HIV testing among substance-using men who have sex with men.Soluble biomarkers of immune activation and inflammation in HIV infection: impact of 2 years of effective first-line combination antiretroviral therapy.Factors Associated with Late Engagement to HIV Care in Western Kenya: A Cross-Sectional Study.Increased costs of HIV care associated with aging in an HIV-infected population.Clinicoepidemiological Profile of Elderly PLHIV Attending a Tertiary Care Center in South India.Virologic failure and mortality in older ART initiators in a multisite Latin American and Caribbean Cohort.Impact of social determinants on antiretroviral therapy access and outcomes entering the era of universal treatment for people living with HIV in Italy.Non-AIDS Mortality Is Higher Among Successfully Treated People Living with HIV Compared with Matched HIV-Negative Control Persons: A 15-Year Follow-Up Cohort Study in Sweden

P2860

Q26772852-7868DE2A-9A6B-415B-BA00-B5DAEFA4A232 Q26775832-7B189FB0-F644-42C6-A9D3-C801ABBE54B4 Q26858824-DC80E871-85BA-457C-A914-65E7C25457A7 Q27003431-6B67A524-E1A4-4F17-B946-947BC7AFE2F8 Q27015965-3F1423AE-1FE2-4B97-BF39-40B51D7D4BC6 Q33653802-9CFA136F-B9F6-4756-B941-F272C505456D Q34870233-C775A24B-B1ED-4CD6-B974-D681A69C450A Q35128754-AE2C9825-DD6C-4BA0-8943-38E1E3039F0D Q35541920-8B7F3E11-818F-4487-BD0A-86EFD82D0BFC Q35873534-423993A5-D6D0-415B-8CD1-2D73F425FEEE Q35897165-7C8E82D8-9BA8-498A-AEE9-0C914AFD2DFC Q35930686-BF441D94-4D24-4A60-B665-32CD9F64B4B3 Q36220805-FE067E50-FF9A-4FE4-AFFC-40EC135BDFAF Q36241636-E661A659-A2A6-4F72-A9CF-22B651226458 Q36275359-28FF515F-62AB-4049-B9E3-AC26EAD8FD74 Q36768319-D4991E6B-3411-4272-86E6-584189F6130E Q37247131-DB65D0BA-803D-449F-A78B-690A6D20A1EF Q37600454-F7845FDC-F643-4CC2-B39F-4BB4831B3B5F Q37692750-C9B3C7EF-735B-4609-A887-B05D6E4D80CD Q37942650-7682B85A-F08C-430F-91CE-6F5B6A1D6AC3 Q38400394-D143D8FA-2CE3-43F5-B2EE-CEB7D7DABB8B Q38684211-5CF25EA1-DFD8-434F-91CC-E6D2B0F1037F Q39795966-A9684E32-3637-422E-9678-1A33475AAE09 Q40188934-19FED808-67C1-4CF1-9224-1155BB772D2C Q40746788-ECDFE5AB-3FBB-4A05-8D04-B3EEE09D69B9 Q41257300-33757292-0A80-470D-B36E-4B5D4D625A29 Q41544667-D9A55BB6-0981-44DF-B2C2-40BF45697623 Q42202635-954DAB2B-54DE-4C1E-AAB0-19064161F29A Q49544561-5918EC5B-FF06-450E-9DED-3D2DAE1BF9E6 Q51760332-315B86B4-C267-47FC-93AB-B07A8D5A5027 Q55645139-5E92B37D-5CD1-4347-855E-58E57E326B2C Q58806024-7768CEE7-0D8C-4F05-83E6-088FDE910678

P2860

CD4 count at presentation for HIV care in the United States and Canada: are those over 50 years more likely to have a delayed presentation?

http://www.wikidata.org/entity/Q34499000

description

2010 nî lūn-bûn

@nan

2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

CD4 count at presentation for ...... o have a delayed presentation?

@ast

CD4 count at presentation for ...... o have a delayed presentation?

@en

CD4 count at presentation for ...... o have a delayed presentation?

@nl

type

label

CD4 count at presentation for ...... o have a delayed presentation?

@ast

CD4 count at presentation for ...... o have a delayed presentation?

@en

CD4 count at presentation for ...... o have a delayed presentation?

@nl

prefLabel

CD4 count at presentation for ...... o have a delayed presentation?

@ast

CD4 count at presentation for ...... o have a delayed presentation?

@en

CD4 count at presentation for ...... o have a delayed presentation?

@nl

P1433

Q34499000-2FB80381-E89A-45FE-B949-896D5463146C

P1476

Q34499000-615832BB-7AF3-420A-AC75-15B6A7F4BC12

P2093

Q34499000-046B252A-B352-497F-B3EC-A060DD83C0D3

Q34499000-0836D5CA-5250-43A2-BA92-C427895390B5

Q34499000-2202BBDE-118F-41AC-AE0A-8C27C2FDA7D1

Q34499000-3B7A47F5-C53C-4F52-B17F-ACB72C3469CC

Q34499000-3E88563C-D61B-438A-965A-901C8E27E42D

Q34499000-4177655D-EC73-46A7-A73F-76FB189A7D9E

Q34499000-4A4504D1-8017-458F-9114-82A892DA398D

Q34499000-4AED1166-1277-4568-ABEA-2AE9420D2DB5

Q34499000-63629ABC-7274-4944-8287-139DB2FF5C09

Q34499000-6B67BDCA-DC3F-4D1F-9D6C-3EA774132D63

P2860

Q34499000-02EC550C-E505-47C7-BC96-21D54E55C8BA

Q34499000-0D1A95AB-5E29-4909-9B01-4567BFCF1617

Q34499000-1FA323DD-B502-4A20-8355-A3E508C98891

Q34499000-2D05EECE-CF48-429B-AB21-814BD0C2070A

Q34499000-33FA4395-F550-4269-9B21-47EADB2A7873

Q34499000-3F628EA3-EF59-483C-8DB0-61215D6FC3AB

Q34499000-50258C2B-D76D-4A66-98D2-F6558A37F2F3

Q34499000-590DCDF3-44CC-426E-AB82-4D992D85EE27

Q34499000-5E9B62A1-7CA9-4371-A3D1-208D8B95365D

Q34499000-8D99EDC9-5C0F-4CFA-B0F7-FE04D2C422DF

P2888

Q34499000-8D57DAAF-C23E-48D3-979B-BFBB9E960F82

P304

Q34499000-E92CC355-68E9-402F-B231-A66004EADF5D

P31

Q34499000-278FC556-4E8A-4AE8-A3FA-338801574844

P356

Q34499000-9FA01250-8F4C-4DDF-96EA-0B4248045299

P478

Q34499000-B5C6E222-C356-4177-B958-8F3BBBAE7EF9

P50

Q34499000-5B19E310-95D8-4C9C-A8F7-8F4946534BDC

Q34499000-6D26997F-EA11-4085-91D1-7994A53E66B9

Q34499000-7E5496FD-4506-4536-8928-A07F6467147B

Q34499000-B104EFF6-7A8F-42F8-BEAB-F8CD114418AD

Q34499000-D05141B9-7DB6-4C0E-A8E4-24D7F7D69509

Q34499000-DC4AD02A-0C9B-49FF-B558-D1147964FD63

Q34499000-E277DEB7-70CE-450C-91D1-CF65E6A18185

Q34499000-EF0F01F9-A903-4585-81B3-60D4CC42ABA6

P577

Q34499000-C94C9DAC-CF10-47E3-8F9C-8AB897152B89

P5875

Q34499000-8EFA30F5-B6AF-4FC6-9768-E6B0E503CB4F

P6179

Q34499000-B89E8C6E-6BE4-41CF-9A9E-95909B126CAA

P698

Q34499000-D7EFA822-AFE5-412F-ABA3-778E0B4FA80F

P921

Q34499000-44EA9F00-84F0-4163-B31B-E97DCADF489A

P932

Q34499000-357309C2-6BB2-4114-BA6A-1A7A493E1B04

P356

P1433

AIDS Research and Therapy

P1476

CD4 count at presentation for ...... o have a delayed presentation?

@en

P2093

Amy C Justice

http://www.w3.org/2001/XMLSchema#string

Anita Rachlis

http://www.w3.org/2001/XMLSchema#string

Ann C Collier

http://www.w3.org/2001/XMLSchema#string

Constance A Benson

http://www.w3.org/2001/XMLSchema#string

Gregory D Kirk

http://www.w3.org/2001/XMLSchema#string

James J Goedert

http://www.w3.org/2001/XMLSchema#string

Jeffrey N Martin

http://www.w3.org/2001/XMLSchema#string

Jennifer Thorne

http://www.w3.org/2001/XMLSchema#string

John T Brooks

http://www.w3.org/2001/XMLSchema#string

Kelly A Gebo

http://www.w3.org/2001/XMLSchema#string

P2860

Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group

Cohort profile: the North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD).

Effect of early versus deferred antiretroviral therapy for HIV on survival.

Late presentation for human immunodeficiency virus care in the United States and Canada.

Maternal levels of plasma human immunodeficiency virus type 1 RNA and the risk of perinatal transmission. Women and Infants Transmission Study Group.

HIV infection in older adults.

Impact of small reductions in plasma HIV RNA levels on the risk of heterosexual transmission and disease progression

Immunologic and clinical responses to highly active antiretroviral therapy in patients with HIV infection aged >50 years.

Response to combination antiretroviral therapy: variation by age.

Age-related immune dysfunction in health and in human immunodeficiency virus (HIV) disease: association of age and HIV infection with naive CD8+ cell depletion, reduced expression of CD28 on CD8+ cells, and reduced thymic volumes.

P2888

P304

45

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1742-6405-7-45

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

Benigno Rodriguez

Michael John Gill

Sonia Napravnik

P577

2010-12-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49684268

http://www.w3.org/2001/XMLSchema#string

P6179

1048307733

http://www.w3.org/2001/XMLSchema#string

P698

21159161

http://www.w3.org/2001/XMLSchema#string

P921

P932

3022663

http://www.w3.org/2001/XMLSchema#string